Company intelligence / Profile preview

BioAustralis

Turrella, New South Wales, Australia

Ownership: Private
Development stage: Other

Overview

BioAustralis is a specialist biotechnology company based in Australia that focuses on the production of high-purity microbial metabolites for research and development. The company leverages fermentation technology to isolate and characterize rare small molecules, including antibiotics, anti-tumor agents, and various toxins. Their extensive catalog serves as a critical resource for academic and industrial researchers in the life sciences, providing reference standards and chemical tools for drug discovery. BioAustralis is recognized for its expertise in natural product chemistry and its ability to supply unique compounds that are often difficult to source elsewhere.

Modalities: Small molecule
Industry: Chemicals & Materials

Beyond the preview

Go deeper on BioAustralis.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioAustralis.

Explore the full profile